Kidney Disease Clinical Trials in Atlanta, Georgia
23 recruitingAtlanta, Georgia
Showing 1–20 of 23 trials
Recruiting
Phase 3
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Chronic Kidney Disease
Boehringer Ingelheim120 enrolled102 locationsNCT07107945
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled475 locationsNCT06531824
Recruiting
Not Applicable
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
Kidney Diseases
Emory University600 enrolled2 locationsNCT06693661
Recruiting
Phase 2Phase 3
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Proteinuric Kidney Disease
Vertex Pharmaceuticals Incorporated466 enrolled318 locationsNCT05312879
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled179 locationsNCT05457283
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled761 locationsNCT06742723
Recruiting
Phase 2
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease
Calico Life Sciences LLC240 enrolled75 locationsNCT06902558
Recruiting
Not Applicable
Incremental Hemodialysis: The TwoPlus Trial
End-stage Kidney Disease
Wake Forest University Health Sciences350 enrolled10 locationsNCT05828823
Recruiting
Phase 2
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
AstraZeneca218 enrolled71 locationsNCT07222917
Recruiting
Not Applicable
SPYRAL GEMINI Pilot Study
Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular175 enrolled16 locationsNCT06907147
Recruiting
Phase 2
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Maze Therapeutics56 enrolled81 locationsNCT06830629
Recruiting
Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuria
Bayer219 enrolled164 locationsNCT05196035
Recruiting
Phase 2
Ferric Citrate and Chronic Kidney Disease in Children
Chronic Kidney Diseases
University of California, Los Angeles160 enrolled20 locationsNCT04741646
Recruiting
Phase 3
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Kidney Transplant; ComplicationsKidney DiseasesCytomegalovirus (CMV)
University of California, San Francisco360 enrolled5 locationsNCT06798909
Recruiting
Not Applicable
Handgrip Exercise Training and CKD
Chronic Kidney Diseases
Emory University50 enrolled1 locationNCT07094906
Recruiting
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Kidney TransplantKidney DiseaseTransplant Recipient+3 more
Devyser Inc.400 enrolled6 locationsNCT07006831
Recruiting
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Kidney Disease, ChronicKidney DiseasesKidney Failure
Wake Forest University Health Sciences5,000 enrolled18 locationsNCT03615235
Recruiting
Phase 2
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-mediated Kidney Disease
AstraZeneca96 enrolled77 locationsNCT06824987
Recruiting
Phase 2
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Chronic Kidney Disease
Emory University156 enrolled2 locationsNCT05928936
Recruiting
Not Applicable
Mindfulness in Chronic Kidney Disease
Chronic Kidney Diseases
Emory University150 enrolled1 locationNCT04099992